Improved Patient Outcomes Require the Internet of Medical Things (IoMT)

An FDAnews FREE Webinar • Sponsored by Kalypso and PTC
Wednesday, Oct. 25, 2017 • 1:30 p.m. - 2:30 p.m. EDT

The Internet of Medical Things (IoMT) and the transition to patient outcomes are changing the way medical device companies approach new product development. Simply stated, IoMT is connected intelligence around:

  • Devices
  • Patients
  • Physicians
  • Healthcare Centers

Medical device companies are learning to utilize IoMT to receive, track and report data – to interact with the internal states and the external environment around them.

Connected devices are allowing companies to perform remote service, optimize preventive maintenance and minimize recalls. Additionally, IoMT mashups are enabling companies to leverage existing investments in ERP, PLM, MES, CRM, LMS and MRP solutions without the traditional rip and replace methodology. This approach allows customers to closely align with the FDA’s Case for Quality initiative to:

  • Reduce Audits
  • Shorten NPI Cycles
  • Reduce the Cost of Poor Quality

At the same time, healthcare models are shifting from the traditional “sick-care” system to a “well-care” system. Changing reimbursement models are enabling healthcare professionals to focus more on remote patient monitoring and chronic care management.

The dramatic increase in the number of connected IoMT devices means you have to understand the potential benefits, and pitfalls, of leveraging them to respond to how the healthcare industry is changing. This is critical to the future of your business….

…. and we have experts at hand to help put all these changes in context so you know how best to respond.

Join Sandra Rodriguez — Market Analyst, Axendia, David Wolf — Senior Manager, Kalypso, Jordan Reynolds — Senior Manager, Kalypso on Oct. 25, 2017 at 1:30 pm, when they’ll discuss how smart, connected products are supporting patient outcomes.

You will learn how:

  • The medical device industry can apply IoMT and outcome based models to achieve patient well-care
  • IoMT and Big Data foster an environment that is conducive to Predicative Analytics and Machine Learning
  • What medical device companies are already doing to compete in a new ecosystem that includes at-home patient monitoring
  • How integrated technology solutions, including PLM, close the loop from ideation through post market surveillance
  • Cybersecurity threats are being mitigated

Who Will Benefit

  • Quality Affairs
  • Medical Directors
  • IT Professionals
  • Research and Development
  • Manufacturing Personnel

Sign Up for FREE Below

Meet Your Presenters


Sandra Rodriguez

Market Analyst, Axendia

Sandra is a Market Analyst at Axendia, an analyst firm providing trusted advice to Life-Science and Healthcare Executives on Business, Technology and Regulatory issues. Sandra has fifteen years of experience working within the FDA-regulated industries and served six years in the US Army Reserve. She has authored numerous articles and white papers on topics such as IoT, Quality Metrics and Digital Transformation.


Jordan Reynolds

Senior Manager, Kalypso

Jordan is a leading expert in digital innovation with management experience across ideation, strategic planning, solution design and program execution. With testimonial success applying both established and cutting-edge innovation capabilities, Jordan has a unique perspective on how his clients can enhance their creative aptitude and maximize their return on innovation investments.


David Wolf

Senior Manager, Kalypso

Prior to joining Kalypso, David worked for medical device manufacturing companies in a variety of roles. He has designed, patented and released several product lines for worldwide distribution. David has hands on expertise in product development, manufacturing, supply chain, regulatory and quality management. He was a catalyst that drove and managed the PTC Medical Device Suite and Validation Packages, which significantly reduces the implementation time and cost for mid-market companies.